Press release from Companies: DBP International AB: next purchase order for Temodex to Columbia

Press release from Companies: DBP International AB: nästa köporder för Temodex till Columbia

Press release from Companies: DBP International AB: clinical batch of SI-053 has been manufactured for the upcoming clinical trial phase 1

Press release from Companies: DBP International AB: klinisk batch av SI-053 har tillverkats för kommande kliniska prövning fas 1

Press release from Companies: DBP International AB: Mexico patent for Temodex / SI-053 is granted

Press release from Companies: DBP International AB: Mexikanskt patent för Temodex/SI-053 är beviljad

Press release from Companies: DBP International AB: ett nytt patent för SA-033 har beviljats i USA

Press release from Companies: DBP International AB: a new patent for SA-033 is granted in USA

Market Notices: Market Notice 149/21 - Information regarding Double Bond Pharmaceutical International AB’s subscription options

Market Notices: Market Notice 148/21 - Last day of trading in Double Bond Pharmaceutical International AB’s BTU

Press release from Companies: DBP International AB: Nyemissionen registrerad

Press release from Companies: DBP International AB: The CTA for SI-053 has been sent - the tenth and the last milestone for the clinical trial of SI-053 has been completed